( lowing us to move forward and explore o...)Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed,Health

lowing us to move forward and explore other treatment strategies sooner than expected," explained Dr. Philip. "These results highlight the value of continued research to develop new drugs to fight pancreatic cancer. It also emphasizes the vital importance of offering patients the option to be on a clinical trial. This expedites the process of discovering better therapies for this difficult disease."

Dr. Philip will also chair today an education session titled, Rational Development of Systemic Therapies for Pancreatic Cancer: Bench to the Bedside, discussing lessons learned in treating pancreatic cancer and summarizing future endeavors based on the current knowledge including the advances in the molecular biology of pancreatic cancer.

Next Generation of Clinical Trials in Pancreas Cancer

The emergence of molecularly targeted agents has led to a dramatic increase in research activity and the number of new clinical trials in patients with all stages of pancreatic cancer. The next generation of clinical trials for pancreatic cancer patients will combine multiple drugs that affect several targets in the cancer cells. Attacking cancer cells from many angles lessens their ability to resist treatment. The ultimate goal is also to develop treatments based on a patient's unique genetic composition.

According to Dr. Philip, it is hoped that nationally increased awareness in the value of clinical trials for cancer patients will allow investigators to ask the maximum number of research questions in the shortest period of time, resulting in more effective therapies available to patients in a shorter amount of time.

ASCO is the world's leading professional organization representing physicians who treat people with cancer. ASCO's members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocat
'"/>

Page: 1 2 3
Related medicine technology :

1. Genetic Analysis Systems Enter the Clinical Mainstream
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Large Geographic Differences in EpiPen Prescriptions in the U.S., From the Journal of Allergy and Clinical Immunology
4. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
5. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
6. Halozyme Therapeutics Enhanze Technology Large Protein Molecule Therapeutic Clinical Trial Results Presented at the 34th Annual Meeting of the Controlled Release Society
7. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference